Inscopix Expands Scientific Advisory Board with Appointment of Leading Neuroscientists
Mountain View, CA, August 9, 2016/-- Inscopix, Inc., announced the addition of four distinguished brain research experts, Botond Roska (FMI), Hongkui Zeng (AIBS), Scott Sternson (Janelia), and Surya Ganguli (Stanford), to its Scientific Advisory Board (SAB). The new members will join Eric Nestler (Mt. Sinai) and Guoping Feng (MIT). The SAB will work closely with Inscopix’s executive, and science and engineering teams to provide strategic guidance for research and development activities in support of the company’s ambitious technology road-map for revolutionizing real-time brain activity mapping.
Speaking at the inaugural meeting of the expanded SAB, Kunal Ghosh, CEO, said, “We are honored to have these accomplished neuroscientists join our SAB. Their collective expertise spans the breadth of neuroscience disciplines, from genetics to circuits to behavior, and from experiment to theory. The SAB members will play a pivotal role in shaping our R&D agenda for developing cutting-edge solutions that will integrate biological reagents, instrumentation, and data analytics for neural-circuit level investigations of brain function in health and in disease”.
Inscopix today is best known for its proprietary miniature microscope technology, nVista, for imaging large-scale neural activity in freely behaving animals. The technology, now in over 150 laboratories across the globe, is enabling scientists to map the function and components of brain circuits, and to decipher the computations that underlie mental activity and behavior.
Hongkui Zeng, Ph.D., is the Executive Director, Structured Science, at the Allen Institute for Brain Science. At Allen, she has led several large-scale research programs including the Transgenic Technology Program, the Human Cortex Gene Survey Project, the Allen Mouse Brain Connectivity Atlas Project, and the Mouse Cell Types Program. Dr. Zeng received her Ph.D. in Molecular and Cell biology from Brandeis University.
Botond Roska, M.D., Ph.D., is a Senior Group Leader at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland. He brings his expertise to the SAB in interdisciplinary approaches, combining molecular biology, physiology, and computational neuroscience, to elucidate the structure and function of neural circuits. He holds a Ph.D. in Molecular and Cell Biology from UC Berkeley.